메뉴 건너뛰기




Volumn 7, Issue 10, 2011, Pages 677-679

Cyclosporine versus infliximab for the treatment of severe ulcerative colitis

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; INFLIXIMAB; PREDNISONE;

EID: 81155137568     PISSN: 15547914     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Note
Times cited : (9)

References (5)
  • 1
    • 80755165415 scopus 로고    scopus 로고
    • Cyclosporin versus infliximab in severe acute ulcerative colitis refractory to intravenous steroids: A randomized trial
    • Presented at May 7-10, Chicago, Illinois. Abstract 619
    • Laharie D, Bourreille A, Branche J, et al. Cyclosporin versus infliximab in severe acute ulcerative colitis refractory to intravenous steroids: a randomized trial. Presented at Digestive Disease Week; May 7-10, 2011; Chicago, Illinois. Abstract 619.
    • (2011) Digestive Disease Week
    • Laharie, D.1    Bourreille, A.2    Branche, J.3
  • 2
    • 52949131525 scopus 로고    scopus 로고
    • Cyclosporine and infliximab as rescue therapy for each other in patients with steroid-refractory ulcerative colitis
    • Maser EA, Deconda D, Lichtiger S, Ullman T, Present DH, Kornbluth A. Cyclosporine and infliximab as rescue therapy for each other in patients with steroid-refractory ulcerative colitis. Clin Gastroenterol Hepatol. 2008;6:1112-1116.
    • (2008) Clin Gastroenterol Hepatol , vol.6 , pp. 1112-1116
    • Maser, E.A.1    Deconda, D.2    Lichtiger, S.3    Ullman, T.4    Present, D.H.5    Kornbluth, A.6
  • 3
    • 79953788483 scopus 로고    scopus 로고
    • GETAID. Successive treatment with cyclosporine and infliximab in steroid-refractory ulcerative colitis
    • Leblanc S, Allez M, Seksik P, et al. GETAID. Successive treatment with cyclosporine and infliximab in steroid-refractory ulcerative colitis. Am J Gastroenterol. 2011;106:771-777.
    • (2011) Am J Gastroenterol. , vol.106 , pp. 771-777
    • Leblanc, S.1    Allez, M.2    Seksik, P.3
  • 4
    • 44249098084 scopus 로고    scopus 로고
    • Optimizing drug therapy in inflammatory bowel disease
    • DOI 10.1007/s11894-007-0068-2
    • Swaminath A, Kornbluth A. Optimizing drug therapy in inflammatory bowel disease. Curr Gastroenterol Rep. 2007;9:513-520. (Pubitemid 351795710)
    • (2007) Current Gastroenterology Reports , vol.9 , Issue.6 , pp. 513-520
    • Swaminath, A.1    Kornbluth, A.2
  • 5
    • 67650639279 scopus 로고    scopus 로고
    • Predictive factors of poor response to intravenous cyclosporine in steroid-refractory ulcerative colitis
    • Huamán Ríos JW, Casellas Jordá F, Malagelada Benaprés JR. Predictive factors of poor response to intravenous cyclosporine in steroid-refractory ulcerative colitis. Rev Esp Enferm Dig. 2009;101:163-171.
    • (2009) Rev Esp Enferm Dig. , vol.101 , pp. 163-171
    • Huamán Ríos, J.W.1    Casellas Jordá, F.2    Malagelada Benaprés, J.R.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.